J&J takes Crohn's med Stelara in new direction, with bolder and brighter outlook
Johnson & Johnson’s Janssen is pointing in a positive, new direction for its Crohn’s disease and ulcerative colitis brand Stelara.
The new campaign called “UnstoppaBOLD” is purposeful in encouraging patients to get back to their “authentic, bold selves,” said Tara Muzsi, Janssen VP, sales and marketing for gastroenterology.
The upbeat initial TV ad, which debuted on the high-profile Grammy music awards show last week, uses the Stelara purple brand color throughout along with an instrumental horns soundtrack from the pop music hit “Cheerleader.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 150,300+ biopharma pros reading Endpoints daily — and it's free.